Research programme: human growth hormone - BiolexAlternative Names: hGH research programme - Biolex; Human growth hormone research programme - Biolex
Latest Information Update: 01 Oct 2012
At a glance
- Originator Biolex
- Class Growth hormones; Hormonal replacements
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- No development reported Somatotropin deficiency